Suchergebnisse - "Baudens, Guy"

PubPharm (22)

1

Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network

enthalten in: Scientific reports | 2024

von Larid, G. | Baudens, G. | Tiemdjo-Djimaffo, G. | +10

2

Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis

enthalten in: Rheumatology international | 2022

von Rodère, M. | Pereira, B. | Soubrier, M. | +12

3

Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis

enthalten in: Rheumatology international | 2022

von Rodère, M. | Pereira, B. | Soubrier, M. | +12

4

Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis

enthalten in: Rheumatology international | 2022

von Rodère, M. | Pereira, B. | Soubrier, M. | +12

5

Differential retention of adalimumab and etanercept biosimilars compared to originator treatments : Results of a retrospective French multicenter study

enthalten in: Frontiers in medicine | 2022

von Larid, G. | Baudens, G. | Dandurand, A. | +10

6

Secukinumab and ustekinumab treatment in psoriatic arthritis : results of a direct comparison

enthalten in: Rheumatology (Oxford, England) | 2021

von Letarouilly, J. | Flachaire, B. | Labadie, C. | +25

7

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis : TANDEM Study

enthalten in: Rheumatology and therapy | 2021

von Hilliquin, P. | Barnetche, T. | Baillet, A. | +10

8

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study

enthalten in: Rheumatology and therapy | 2020

von Hilliquin, P. | Barnetche, T. | Baillet, A. | +10

9

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study

enthalten in: Rheumatology and therapy | 2020

von Hilliquin, P. | Barnetche, T. | Baillet, A. | +10

10

Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study

enthalten in: Rheumatology and therapy | 2020

von Hilliquin, P. | Barnetche, T. | Baillet, A. | +10